7 hasil untuk "Kenneth Adea"
Menampilkan 1–7 · 0,83 detik · RSS
-
Artikel Jurnal
AH971 and AV865 antibodies label the SARS-CoV-2 nucleocapsid protein in focus-forming assay
AH971 and AV865 antibodies detect the nucleocapsid proteins of severe acute respiratory SARS coronavirus-2 (SARS-CoV-2) in a focus forming assay.
-
Artikel Jurnal
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responsesResearch in context
Summary: Background: Mucosal antibodies play a key role in the protection against SARS-CoV-2 infection in the upper respiratory tract, and potentially in limiting virus replication and therefore onward transmission. While systemic immunity to SARS-CoV-2 is well understood, we have a limited…
-
Artikel Jurnal
Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant
ABSTRACT The emergence of each novel SARS-CoV-2 variant of concern (VOC) requires investigation of its potential impact on the performance of diagnostic tests in use, including antigen-detecting rapid diagnostic tests (Ag-RDTs). Although anecdotal reports have been circulating that the newly…
-
Artikel Jurnal
SARS-CoV-2 delta and omicron variants alter trophoblast cell fusion and syncytiotrophoblast dynamics: new insights into placental vulnerability
Abstract Pregnancy is associated with an increased risk of severe COVID-19. In addition, SARS-CoV-2 infection during gestation has been linked to adverse obstetrical outcomes and placental abnormalities. Nevertheless, the susceptibility of early trophoblast cells to SARS-CoV-2 and the potential…
-
Artikel Jurnal
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
Emerging SARS-CoV-2 variants raise concerns on protective immunity. Here the authors show that convalescent sera from people infected with Alpha, Beta, Gamma or Delta show a significant drop of Omicron-BA.1 neutralization and that vaccine-breakthrough infections with Omicron-BA.1 or Delta result in…